Breaking News

Almac Expands Commercial API Manufacturing

The facility is expected to be built and validated within the next two years.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Almac is expanding its manufacturing capacity to more 30m3 at its European headquarters in Craigavon, UK. The upgraded facility will include reactor vessels with clean room product isolation and drying equipment to allow Highly Potent API manufacture up to 600kg batch size. Denis Geffroy, vice president of business development, said,  “We are delighted with the progress made over the past two years to increase our presence in late phase clinical development. This capacity increase will allow a ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters